Metraipolis › archive › dc_671c3de93e90

TMEM92 drives EMT-associated invasiveness, cisplatin resistance, and immune suppression in head and neck squamous cell carcinoma — Europe PMC PMID:42045453

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42045453
DOI
10.1038/s41598-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-03T02:01:41.790Z
SHA-256 of the archived text
cd5d8d258794d7be6f5a3653d491489ff4ea2e56a8b1021c75140c9f00445468
Stable URL of this page
https://metraipolis.com/documento/dc_671c3de93e90

How to cite

TMEM92 drives EMT-associated invasiveness, cisplatin resistance, and immune suppression in head and neck squamous cell carcinoma — Europe PMC PMID:42045453 — Europe PMC (en), https://europepmc.org/article/MED/42045453 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_671c3de93e90 (Metraipolis archive dc_671c3de93e90, sha256 cd5d8d258794d7be6f5a3653d491489ff4ea2e56a8b1021c75140c9f00445468)
BibTeX
@misc{dc671c3de93e90,
  title = {TMEM92 drives EMT-associated invasiveness, cisplatin resistance, and immune suppression in head and neck squamous cell carcinoma — Europe PMC PMID:42045453},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42045453},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_671c3de93e90; sha256 cd5d8d258794d7be6f5a3653d491489ff4ea2e56a8b1021c75140c9f00445468},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42045453. Agents can read the archived copy with the MCP tool read_document.